April 25 Application Review Subcommittee Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
APPLICATION REVIEW SUBCOMMITTEE OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH, TREATMENTS, AND CURES INITIATIVE OF 2020

Date: April 25, 2024
Time: 9:00 am to 9:45 am*
Address: 601 Gateway Blvd., Suite 400
South San Francisco, CA 94080


This meeting of the Application Review Subcommittee will be conducted in person and via noticed teleconference locations, which will be made accessible to the public. Members of the public may attend this meeting in person at the address printed above, at a teleconference location listed below, or remotely via the options listed below.

 

Teleconference Locations

500 Parnassus Avenue, San Francisco, CA 94143 5950 Canoga Ave, Suite 110, Woodland Hills, CA 91367
21211 Rainbow Drive. Cupertino, CA 95014 2619 Montclair St., San Diego, CA 92104
1580 Henry Rd., Napa, CA 94559 327 McCartney Ct,. Lincoln, CA 95648
10996 Torreyana Road, Suite 200, San Diego, CA 92121 9301 Wilshire Blvd. Ste. 507, Beverly Hills, CA 90210
KN 5 Rd, Kigali, Rwanda 6220 Playa Vista Place, Avila Beach, CA 93424

 

Public Comment Instructions

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: 

  • Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment.
  • Once we call your name you may have up to 3 Minutes (depending on the number of members of the public wishing to speak) to make your public comment; please remember to be respectful of the time limit.
  • Written comment may be sent to the following email address: cmandac@cirm.ca.gov
  • Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location with the same limitations as those imposed on any other member of the public.

 

YouTube:
https://www.youtube.com/cirmtv

Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 879 0584 9987
Passcode: 240425

 

Open Session

  1. Call to Order
  2. Roll Call
  3. Consideration of Applications Submitted in Response to Clinical Trial Stage Projects Program Announcements (CLIN 1 or 2)

 Closed Session

  1. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda item 3 above. (Health & Safety Code 125290.30(f) (3) (B) and (C)). 

Open Session

  1. General Comments on ARS Process
  2. Public Comment
  3. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Claudette Mandac at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Claudette Mandac at the California Institute for Regenerative Medicine at cmandac@cirm.ca.gov.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov/

The subcommittee may take action on any item listed on this agenda.

*The duration of the meeting is an estimate, only. The meeting may continue beyond this estimated time in order to address the items on this agenda.

Transcripts

Date Published: April 15, 2024
Last Modified: April 26, 2024